Dr. Sven Abbott

Thoracic medical oncologist · Policlinico Gemelli · Italy (IT) · Oncology

Tier 2STK-0005GoodOwner MSL MTMei Tanaka

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: PD-L1 biomarkers
Engagement preference: In person
Advisory boards: 0
Publications: 49
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 05 Jun 2026 (102 days ago)
Next planned contact: 05 Dec 2026
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (1)

INS-0020Infusion-reaction management
05 Jun 2026 · Diagnosis and screening
MediumOutcome recorded

Engagement history (1)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
05 Jun 2026	Scientific exchange	Virtual	Mei Tanaka	Vantrexa	Infusion-reaction managementElderly / ECOG 2 patients	1	—	Reviewed	ENG-0086

Timeline

05 Jun 2026
Scientific exchange
Infusion-reaction management, Elderly / ECOG 2 patients

Related stakeholders (5)

Policlinico Gemelli

Dr. Daniel Tanaka
Thoracic medical oncologist
Tier 3
Dr. Zoë Yamamoto
Thoracic medical oncologist
Tier 1
Dr. Tomoko Vogel
Radiation oncologist
Tier 2
Dr. Ingrid Dubois
General neurologist
Tier 3
Dr. Quentin Eriksen
Headache specialist
Tier 3